You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 16, April 26, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (34)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Case-Control Study of Caffeine and Methylxanthines in Benign Breast Disease

Flora Lubin; Elaine Ron, PhD; Yochanan Wax; Maurice Black, MD; Michaela Funaro, MSc; Angela Shitrit, MA

JAMA. 1985;253(16):2388-2392.


Abstract

A dietary case-control study of 854 histologically diagnosed cases of benign breast disease (BBD), 755 matched surgical controls, and 723 matched neighborhood controls was conducted in Israel between 1977 and 1980. No association between coffee consumption and BBD was found. Analyses by histological type, degree of ductal atypia, age, sex, and ethnic origin, controlling for several confounding factors, confirmed the lack of association. The estimated mean intake of methylxanthines was also similar for cases and controls (302, 312, and 313 mg for cases, surgical controls, and neighborhood controls, respectively). No evidence of a dose-response was noted. Our results suggest that there is no association between coffee or methylxanthine consumption and BBD, although we had a 70% chance of finding a risk ratio of 1.5 with an error of 5%.

(JAMA 1985;253:2388-2392)



Author Affiliations

From the Department of Clinical Epidemiology, Chaim Sheba Medical Center, Tel Hashomer, Israel (Mss Lubin, Funaro, and Shitrit and Drs Ron and Wax); and the New York Medical College, Westchester County Medical Center, Valhalla. NY (Dr Black).


Footnotes

Reprint requests to Department of Clinical Epidemiology, Chaim Sheba Medical Center, 52621 Tel Hashomer, Israel (Ms Lubin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dietary Intake Changes and Their Association with Ovarian Cancer Risk
Lubin et al.
J. Nutr. 2006;136:2362-2367.
ABSTRACT | FULL TEXT  

A Prospective Study of Diet and Benign Breast Disease
Webb et al.
Cancer Epidemiol. Biomarkers Prev. 2004;13:1106-1113.
ABSTRACT | FULL TEXT  

Evaluation and Management of Breast Pain
Smith et al.
Mayo Clin Proc. 2004;79:353-372.
ABSTRACT  

Risk factors for benign proliferative breast disease
Friedenreich et al.
Int J Epidemiol 2000;29:637-644.
ABSTRACT | FULL TEXT  

Caffeine and Benign Breast Disease
Jacobson and Liebman
JAMA 1986;255:1438-1439.
ABSTRACT  

Caffeine and Benign Breast Disease
Minton
JAMA 1985;254:2408-2408.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.